Compumedics Ltd (ASX: CMP) Share Price and News
Price
Movement
(20 mins delayed)
52 Week Range
-
1 Year Return
Compumedics Ltd Chart and Price Data
Fundamentals Data provided by Morningstar.
Data provided by Morningstar.
Market Cap
$47.94 million
P/E Ratio
218.18
Dividend Yield
0.00%
Shares Outstanding
199.76 million
Earnings per share
0.000
Dividend per share
N/A
Year To Date Return
-28.36%
Earnings Yield
0.46%
Franking
-
Share Price
Day Change
52 Week Range
-
Yesterday's Close
Today's Open
Days Range
-
Volume
Avg. Volume (1 month)
Turnover
as at 24 Feb 3:44pm
Compumedics Ltd (ASX: CMP)
Latest News
⏸️ Investing
Why these 4 ASX shares started the week in the red
⏸️ Investing
Why the Compumedics Limited share price fell 19% today
⏸️ Investing
Why these 4 ASX shares are ending the week deep in the red
⏸️ Investing
Why these 4 ASX shares have jumped higher today
⏸️ Investing
Why the Compumedics Limited share price rocketed 43% higher
⏸️ Investing
3 ASX shares at 52-week lows: Are they in the bargain bin?
⏸️ Investing
Top stock picks for February
⏸️ Investing
4 small-cap healthcare shares that you need to know about
⏸️ Investing
3 small-cap shares on my radar for 2017
⏸️ Investing
4 shares under $1 with huge potential
⏸️ Investing
5 small caps that could be the blue-chips of tomorrow
❮2
CMP ASX Announcements
An announcement is considered as "Price Sensitive" if it is thought that it may have an impact on the price of the security.
| Date | Announcement | Price Sensitive? | Time | No. of Pages | File Size |
|---|---|---|---|---|---|
| YesNo |
About Compumedics Ltd
Compumedics Ltd. is engages in the research, development, manufacture and distribution of medical equipment. It offers innovative computer based diagnostic technologies in the areas of sleep, neurology and cardiology. The firm operates through the following geographical segments: United States of America, Australia and Asia Pacific, and Europe. The company was founded by Burton David in 1987 and is headquartered in Abbotsford, Australia.
CMP Share Price History Data provided by Morningstar.
| Date | Close | Change | % Change | Volume | Open | High | Low |
|---|---|---|---|---|---|---|---|
| 23 Oct 2026 | $0.24 | $0.00 | 0.00% | 70,185 | $0.24 | $0.24 | $0.24 |
| 22 Oct 2026 | $0.24 | $-0.01 | -4.00% | 6,350 | $0.25 | $0.25 | $0.24 |
| 21 Oct 2026 | $0.25 | $0.01 | 4.08% | 127,536 | $0.25 | $0.25 | $0.25 |
| 20 Oct 2026 | $0.25 | $0.01 | 4.17% | 4,040 | $0.25 | $0.25 | $0.25 |
| 13 Oct 2026 | $0.24 | $-0.01 | -4.08% | 73,342 | $0.25 | $0.25 | $0.24 |
| 09 Oct 2026 | $0.25 | $-0.02 | -7.69% | 203,803 | $0.25 | $0.25 | $0.25 |
| 07 Oct 2026 | $0.26 | $0.00 | 0.00% | 28,121 | $0.26 | $0.26 | $0.26 |
| 06 Oct 2026 | $0.26 | $0.00 | 0.00% | 42,345 | $0.26 | $0.26 | $0.26 |
| 05 Oct 2026 | $0.26 | $0.00 | 0.00% | 61,538 | $0.27 | $0.28 | $0.26 |
| 02 Oct 2026 | $0.26 | $0.02 | 8.33% | 123,300 | $0.25 | $0.26 | $0.25 |
| 01 Oct 2026 | $0.24 | $0.00 | 0.00% | 5,000 | $0.24 | $0.24 | $0.24 |
| 30 Sep 2026 | $0.24 | $0.01 | 4.35% | 12,477 | $0.24 | $0.24 | $0.24 |
| 29 Sep 2026 | $0.23 | $-0.01 | -4.17% | 25,000 | $0.23 | $0.23 | $0.23 |
| 25 Sep 2026 | $0.24 | $0.00 | 0.00% | 11,398 | $0.24 | $0.24 | $0.24 |
Directors & Management Data provided by Morningstar.
| Name | Title | Start Date | Profile |
|---|---|---|---|
| Dr David Burton | Chief Executive OfficerExecutive ChairmanExecutive Director | Nov 1987 |
Dr Burton is the founder and major shareholder through a related entity. His background includes the design and project management of Compumedics' first sleep laboratory and portable sleep systems. He has authored fifteen patents or patent applications that form part of Compumedics' key intellectual property. He has experience in the development, design, manufacture and sale of medical devices and in business development. He is also Chairman of the Board.
|
| Mr David Lawson | Chief Financial OfficerCompany SecretaryExecutive Director | Oct 2013 |
Mr Smith has experience in the development of the Compumedics business over the last 26 years and previously held several management positions with another listed public entity.
|
| Mr Rod James North | Non-Executive Director | Oct 2022 |
Mr North has over 30 years of experience in the financial and corporate sectors, having worked in share broking, investment and funds management, and in investor relations, media, and public relations for a range of ASX-listed companies over the past 19 years. He has experience in company analysis and financial management and has served on several investment committees in funds management. He has also acted in advisory roles to private and public companies at senior executive and board levels, focusing on capital raisings, communication, and investor relations strategies.
|
| Warwick Freeman | Chief Technology Office |
-
|
Top Shareholders Data provided by Morningstar.
| Name | Shares | Capital |
|---|---|---|
| D & Dj Burton Holdings Pty Ltd | 96,002,819 | 49.94% |
| HSBC Custody Nominees (Australia) Limited | 11,569,649 | 6.02% |
| B & R James Investments Pty Limited | 5,000,000 | 2.60% |
| Beijing Bestmed Tech Ltd | 4,901,961 | 2.55% |
| Medigas Italia S R L | 4,333,333 | 2.25% |
| Mr David Francis Lawson & Ms Michelle Gabrielle Callinan | 2,464,482 | 1.28% |
| Electro Molecular Pty Ltd | 2,220,072 | 1.15% |
| Valui Pty Ltd | 1,920,987 | 1.00% |
| BNP Paribas Noms (Nz) Ltd | 1,606,224 | 0.84% |
| Ms Karin Jones | 1,489,492 | 0.77% |
| Mr Mark David Holder | 1,230,000 | 0.64% |
| Knowler Property Pty Ltd | 1,198,000 | 0.62% |
| Jarvsofaks Pty Ltd | 1,168,373 | 0.61% |
| Mr Bernard Frederick Knowler & Mrs Robynne Lynette Knowler | 1,120,000 | 0.58% |
| Avianto Pty Ltd | 1,079,975 | 0.56% |
| Mr Nigel Strong | 1,008,786 | 0.52% |
| Mr David Francis Lawson | 1,006,242 | 0.52% |
| P Morgan Nominees Australia Pty Limited | 913,989 | 0.48% |
| Bfa Super Pty Ltd | 778,188 | 0.40% |
| Cowan Grant Pty Ltd | 768,000 | 0.40% |
